Adult male or female patients, with proven COVID-19 moderate disease with any one of respiratory rate 24- 30/min, breathlessness, SPO2 90-93% on room air will be included in the study.

Adult male or female patients, with proven COVID-19 moderate disease with any one of respiratory rate 24- 30/min, breathlessness, SPO2 90-93% on room air will be included in the study.